Literature DB >> 28950181

Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus.

N A Abdella1, O A Mojiminiyi2.   

Abstract

AIMS: This study explores the determinants of sex hormone binding globulin (SHBG) and associations with categories of glucose intolerance and undiagnosed diabetes in first-degree relatives (FDR) of patients with Type 2 Diabetes Mellitus (T2D).
METHODS: Anthropometric indices, fasting lipids, glucose, insulin, adiponectin, leptin, SHBG, estradiol (E2), testosterone (TT), androstenedione (AND), dehydroepiandrosterone sulphate (DHEA-S), high-sensitivity C-reactive protein (hs-CRP) and alanine aminotransferase (ALT) were measured in 584 FDR. Homeostasis model assessment-estimate of insulin resistance (HOMA-IR), beta cell function (%B), insulin sensitivity (%S) and free androgen index (FAI) were calculated.
RESULTS: 266 subjects were normoglycemic; 237 had prediabetes and 81 had undiagnosed diabetes. SHBG decreased stepwise with worsening categories of glucose intolerance in females whereas FAI decreased stepwise with worsening categories in males only. SHBG showed significant positive correlations with adiponectin, and HDL-C and significant negative correlations with body mass index (BMI), waist circumference (WC), Waist:hip ratio (WHR), ALT, triglycerides (TG), %B, leptin and FAI. After adjustment for WHR, only HDL-C and FAI in men and FAI and HbA1c in females remained significantly associated with SHBG. Receiver Operating Characteristic (ROC) curve analysis for detection of diabetes showed that areas under the curve for FAI and SHBG were 0.711 and 0.386 for males and 0.430 and 0.660 for females respectively.
CONCLUSION: Associations of SHBG with some anthropometric and metabolic variables in FDR suggests that lower levels is a marker for risk of developing T2D through obesity dependent metabolic pathways but low FAI is a better marker of state of diabetes in males.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  First-degree relatives; Glucose intolerance; Sex hormone binding globulin; Type 2 Diabetes Mellitus

Mesh:

Substances:

Year:  2017        PMID: 28950181     DOI: 10.1016/j.diabres.2017.08.024

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population.

Authors:  Nabila A Abdella; Olusegun A Mojiminiyi
Journal:  J Diabetes Res       Date:  2018-05-20       Impact factor: 4.011

2.  Clinical Applications of Adiponectin Measurements in Type 2 Diabetes Mellitus: Screening, Diagnosis, and Marker of Diabetes Control.

Authors:  Nabila A Abdella; Olusegun A Mojiminiyi
Journal:  Dis Markers       Date:  2018-07-05       Impact factor: 3.434

3.  Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome.

Authors:  Aleksandra Biernacka-Bartnik; Piotr Kocełak; Aleksander Jerzy Owczarek; Piotr Choręza; Monika Puzianowska-Kuźnicka; Leszek Markuszewski; Paweł Madej; Jerzy Chudek; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2022-01-31       Impact factor: 3.257

4.  Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men.

Authors:  Prabin Gyawali; Sean A Martin; Leonie K Heilbronn; Andrew D Vincent; Alicia J Jenkins; Andrzej S Januszewski; Anne W Taylor; Robert J T Adams; Peter D O'Loughlin; Gary A Wittert
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

5.  Overfeeding-induced weight gain elicits decreases in sex hormone-binding globulin in healthy males-Implications for body fat distribution.

Authors:  Prachi Singh; Naima Covassin; Fatima H Sert-Kuniyoshi; Kara L Marlatt; Abel Romero-Corral; Diane E Davison; Ravinder J Singh; Michael D Jensen; Virend K Somers
Journal:  Physiol Rep       Date:  2021-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.